Skip to main content

Table 3 Alternatives, attributes and levels for the DCE

From: What, who and when? Incorporating a discrete choice experiment into an economic evaluation

Defining the alternatives Alternative Names
The Community Pharmacy Medicines Management Project Evaluation Team (8); Tinelli et al. (13)
Medman patient survey data, analysed using Exploratory Factor Analysis (15)
- Medicines review by GP & pharmacist (GP&PH)
- Medicines review by GP only (GP)
- ‘Current’ situation
Defining the attributes/levels Attribute name Levels and regression coding
Ryan et al. (11); Payne et al. (12)
Medman patient survey data, analysed using Exploratory Factor Analysis (15)
‘Advice’ [advice on medicines & health/ lifestyle] - No advice a
- Only on medicines (ADVMED)
- Only on health/lifestyle (ADVHL)
- On medicines & health/lifestyle (ADVMH)
Payne et al. (12)
Medman patient survey data, analysed using Exploratory Factor Analysis (15)
‘Privacy’ in the pharmacy [consultation with your pharmacist is in a private area] - No a
- Yes (PRIVD)
Tinelli et al. (13); Payne et al. (12)
Medman patient survey data, analysed using Exploratory Factor Analysis (15)
‘Time’
[time spent travelling to, waiting in the pharmacy]
10 min; 20 min; 30 min; 40 min (TIME)
Medman patient survey data, analysed using Exploratory Factor Analysis (15) ‘Satisfactory replies’ to your questions - No a
- Yes (REPLD)
The Community Pharmacy Medicines Management Project Evaluation Team (8); Tinelli et al. (13) ‘Chance’ of receiving appropriate treatment - Very poor (CH0)
- Poor (CH1)
- Good (CH2)
- Very good a
Ryan et al. (11); Payne et al. (12); Tinelli et al. (13) ‘Cost’; How much you have to pay (as an indicator of value)
[cost of the medicine + the cost of the medicines review and advice received + the cost of any travel]
£0; £10; £20; £30 (COST)
  1. a Reference level